FIELD: biotechnology.
SUBSTANCE: invention relates to E. coli RosettaTM strain (pRARE2, pR752), RNCIM B-11308. This strain is a producer of a modular nanoconveyor to increase the specificity and effectiveness of antitumor agents of 6His-HMP-NLS-DTox-(Gly-Ser)5-EGF. The present invention makes it possible to obtain a modular 6His-HMP-NLS-DTox-(Gly-Ser)5-EGF nanoconveyor.
EFFECT: increase in the specificity and effectiveness of antitumor agents.
2 dwg, 2 ex
Authors
Dates
2017-12-21—Published
2015-10-28—Filed